蜂毒素分子的改造及其基因在毕赤酵母中的表达

为获得保留有抗菌活性而降低溶血作用的蜂毒素,对蜂毒素的分子结构进行了改造。将第5位的Val变为Arg,第15位Ala变为Arg,删除了第16位的Leu。用PCR技术获得了改造后的蜂毒素基因,将其克隆入酵母表达载体pPICZa-A,获得重组表达质粒pPICZa-A-MEA。该质粒转化毕赤酵母菌GS115,甲醇诱导下表达,发酵上清液经抑菌活性、溶血活性测定及亲和层析纯化,结果表明,蜂毒素基因成功地在毕赤酵母中表达,经改造后表达的蜂毒素保留了抗菌活性且溶血活性显著降低,经纯化后用Bradford法测定表达蜂毒素的含量约为0.29mg／ml。     

蜂毒素分子的改造及其基因在毕赤酵母中的表达

为获得保留有抗菌活性而降低溶血作用的蜂毒素,对蜂毒素的分子结构进行了改造.将第5位的Val变为Arg,第15位Ala变为Arg,删除了第16位的Leu.用PCR技术获得了改造后的蜂毒素基因,将其克隆入酵母表达载体pPICZa-A,获得重组表达质粒pPICZa-A-MEA.该质粒转化毕赤酵母菌GS115,甲醇诱导下表达,发酵上清液经抑菌活性、溶血活性测定及亲和层析纯化,结果表明,蜂毒素基因成功地在毕赤酵母中表达,经改造后表达的蜂毒素保留了抗菌活性且溶血活性显著降低,经纯化后用Bradford法测定表达蜂毒素的含量约为0.29mg/ml.     

蜂毒素基因的突变与表达及其构效关系研究

为获得保留有抗菌活性而降低溶血活性作用的蜂毒素,对其分子结构进行了改造.其中一条序列缺失Lys-7,另一条缺失Leu-9.用PCR技术获得两条新的蜂毒素基因,将其克隆到酵母表达载体pPICZα-A,获得重组质粒pPICZα-A-Mel1和pPICZα-A-Mel2.将2个重组质粒分别转化毕赤酵母菌GS115.筛选获得重组酵母菌.对重组酵母菌培养条件进行优化,在YEPD中含甘油2%,pH为7,重组酵母菌培养48h后,0.5%的甲醇诱导72h,表达目的蛋白通过Tricion-SDS-PAGE确定分子质量为5.4kD.杀菌效价分别达0.947、1.085.结果表明两条蜂毒素基因成功的在毕赤酵母中表达,经突变后表达的蜂毒素降低了溶血活性,同时保留了抗菌活性.     

致病性猪链球菌2型溶血素基因的克隆与表达

目的：克隆溶血素基因,为评价溶血素的毒力与抗原活性,构建猪链球菌疫苗提供依据。方法：从致病性猪链球菌II型四川资阳分离株基因组中分离溶血素基因,经中间T载体,将其克隆至改造的pGEX-6p1中,最后通过蛋白质电泳和溶血实验检验溶血素的表达及活性。结果：SDS-PAGE结果表明,重组溶血素在5h表达水平最高,10h次之,15h最弱;溶血实验重组菌周围形成明显的透明溶血环。结论：溶血素为分泌性早期表达,具有正常的β溶血活性。     

猪PR-39抗菌肽基因在毕赤酵母中的表达

[目的]在毕赤酵母中表达抗菌肽PR-39基因,获得有抗菌活性的PR-39。[方法]根据酵母和猪密码子偏好性,对其密码子进行优化改造。将经SOE-PCR获得的PR-39基因与毕赤酵母表达载体pPIC9K连接,构建重组载体pPIC9K-PR-39。经SacⅠ线性化电击转化毕赤酵母GS115,取阳性克隆进行髙拷贝转化子筛选和诱导表达。[结果]pPIC9K-PR-39重组质粒构建成功,pPIC9K-PR-39菌株发酵产物检测结果对DH5α大肠杆菌和金黄色葡萄球菌都有抑菌效果。[结论]获得了PR-39基因的重组酵母,并用毕赤酵母系统成功地分泌表达了具有明显抗菌活性的抗菌肽PR-39。     

草鱼生长激素基因在毕赤酵母中的表达

将草鱼生长激素基因（cGH）的cDNA亚克隆到酵母表达载体pPIC9K中,经电击转化导入毕赤巴斯德酵母GS115菌株,获得转化子。菌落PCR技术筛选证实cGH已经整合到了酵母染色体上。对重组酵母进行诱导表达,SDS-PAGE和Western印迹分析,结果表明cGH的毕赤巴斯德酵母GS115菌株中获得了高效表达。     

植酸酶phyAm基因结构延伸突变改善酶的热稳定性

将来源于黑曲霉N25的植酸酶基因phyA^m重组于大肠杆菌表达载体pET-30b（＋）,以重组表达载体pET30b-FphyA^e为模板经PCR扩增获得结构延伸突变植酸酶基因phyA^m（在植酸酶基因C端增加了来源于pET-30b-FphyA^m载体上13氨基酸残基）。含突变基因的重组表达载体pPIC9k-phyA^e在GS115酵母中表达。纯化的突变酶pp-NP^e与野生型酶PP-NP^m-8相比：PP-NPA^e的最适反应温度上升了3气,75℃处理10min,热稳定性提高21％,比活力略有提高。最适反应pH为5．6,有效pH范围pH4,6到pH6．6。比未突变酶扩大了0.4单位。     

肠三叶因子表达载体构建及在酵母菌GS115中的表达

目的:构建肠三叶因子(ITF)的真核表达载体,并在酵母菌GS115中表达,为进一步研究ITF的生理和药理功能奠定基础。方法:通过RT-PCR获得ITF cDNA片断,将目的基因插入pPICZαA酵母表达载体,得到重组载体pPICZαA-ITF。经BspHI线性化后氯化锂转化进入GS115,Zeocin筛选转化酵母菌,PCR鉴定目的基因。阳性转化子经摇瓶表达,取上清TCA沉淀后做Tricine SDS-PAGE分析及Western blot检测表达蛋白。结果:经测序及PCR证实ITF cDNA准确插入酵母表达载体pPICZαA中。Tricille SDS-PAGE分析证明ITF的分子量约为14×10~3,表达蛋白具有良好的抗原性和特异性。结论:成功构建了真核表达载体pPICZαA-ITF,在酵母菌GS115中表达,获得重组ITF蛋白。     

重叠延伸PCR法克隆人脂联素基因及其在毕赤酵母中表达

利用重叠延伸PCR法克隆出人脂联素基因, 连接至克隆载体pGEM-T中, 转化大肠杆菌DH5a, 通过测序对其进行序列分析后, 进一步构建毕赤酵母表达载体pPIC3.5K-ADPN, 通过电击法转化毕赤酵母GS115, 转化的重组酵母菌用甲醇诱导外源基因表达。经PCR、Southern blotting鉴定, 获得了重组毕赤酵母菌株; 经甲醇诱导人脂联素基因表达, Western blotting杂交鉴定证明人脂联素基因已经在毕赤酵母中成功表达。结果表明重叠延伸PCR法准确方便克隆出人脂联素基因, 在30oC, 1%甲醇诱导48 h, 人脂联素基因在巴斯德毕赤酵母中的表达最佳。     

唾液酸化路易斯-X合成关键酶基因的克隆表达

唾液酸化路易斯-X(sialyl lewis X,Slex) 是选择素家族的一个共同糖配体,通过与选择素竞争性地结合炎性细胞,可以抑制炎症反应。通过克隆表达Slex合成过程中的关键酶,在体外进行Slex的生物合成,用于相关乳腺炎防治药物的研发。β-1,4-半乳糖基转移酶(β-1, 4-galactosyltransferase,GT)就是参与Slex生物合成过程的关键酶之一。利用相关软件对牛的GT基因进行了生物信息学的分析,了解了GT的相关理化性质。通过人工合成的方法获得了GT基因的CDS,构建了重组质粒pMD18-GT,并亚克隆至表达载体pPIC9K。通过电转化将线性化的表达质粒pPIC9K-GT整合到宿主菌P. pastoris GS115基因组上,构建了重组酵母GS115-GT。经诱导表达后,SDS-PAGE检测到了目的蛋白条带,证明了此基因在P. pastoris GS115中能够可溶性表达;并用苯酚红法测定了粗酶液的活性,其比酶活为16.4 U/ml,这为其进一步研究奠定了基础。     

Cholesterol inhibits the lytic activity of melittin in erythrocytes

Although cell lysis by the hemolytic peptide, melittin, has been extensively studied, the role of specific lipids of the erythrocyte membrane on melittin-induced hemolysis remains unexplored. In this report, we have explored the modulatory role of cholesterol on the hemolytic activity of melittin by specifically depleting cholesterol from rat erythrocytes using methyl-beta-cyclodextrin (MbetaCD). Our results show that the hemolytic activity of melittin is increased by approximately 3-fold upon depletion of erythrocyte membrane cholesterol by approximately 55% without any appreciable loss of phospholipids. This result constitutes the first report demonstrating that the presence of cholesterol inhibits the lytic activity of melittin in its natural target membrane, i.e., the erythrocyte membrane. These results are relevant in understanding the role of cholesterol in the mechanism of action of melittin in the erythrocyte membrane.     

蜂毒溶血肽作用机理研究进展

该文系统归纳了蜂毒溶血肽的生物学功能,分子结构与性质,溶解血细胞的机理,以及溶血和抑菌活性与结构的关系, 并结合本实验室研究着重综述了近年来国内外对蜂毒溶血肽作用机理的研究。 提出今后研究应该向定量化方向发展,应用计算技术深入阐明蜂毒肽作用的动力学过程及结构与功能的关系,为今后指导分子设计打下一定的理论基础。     

Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin

Although melittin's hemolytic activity has been extensively studied, the orientation of membrane-bound melittin remains uncertain. We have investigated the effect of individually omitted amino acid residues on melittin's activity and related these results to the existing models of melittin-membrane interaction. The extent of hemolysis of the omission analogues closely followed the four known conformational regions of melittin: omission of any of the residues making up the two alpha-helical regions decreased the hemolytic activity relative to melittin, while omission of any of the residues making up the "hinge" or the C-terminal regions had little or no effect. Our results correlate best with a proposed model in which melittin initially forms "holes" in the membrane, resulting in an initial rapid loss of hemoglobin; the membrane-bound melittin is then internalized into the membrane, resulting in a later slow phase of hemoglobin loss. It was also found that induced structural effects caused by peptide-lipid interactions could be studied by using RP-HPLC, with an excellent correlation found between the retention times of the individual omission analogues and their hemolytic activities.     

Electron microscopic observation of the aggregation of membrane proteins in human erythrocyte by melittin

Human erythrocytes and erythrocyte ghost membranes were treated with native and modified melittins, up to 250 nmol/mg membrane protein. Native melittin induced aggregation of intramembranous particles (IMPs, observed by freeze-fracture electron microscopy), and created large, smooth bilayer areas devoid of IMP. The degree of IMP aggregation increased with increasing concentration of melittin, corresponding to hemolysis results. Membrane ghosts were slightly more susceptible to IMP aggregation than membranes on intact cells. The potency of inducing IMP aggregation was ranked in the order of: native melittin greater than acetylated melittin greater than succinylated melittin = 0. The concentration range of melittin which caused IMP aggregation corresponded to that which caused the immobilization of band 3 proteins as detected by measurement of rotational mobility by transient dichroism (Dufton et al. (1984) Eur. J. Biophys. 11, 17-24). Because both IMP aggregation and band 3 protein immobilization decreased with decreasing positive charge of the melittins used, the nature of melittin-protein interaction is likely to be at least in part electrostatic in the case of human erythrocyte membranes. Possible roles of IMP aggregation and the consequent creation of 'exposed' bilayer areas in the cytotoxic reaction of melittins are discussed.     

Identification of the discontinuous epitope in human complement protein C9 recognized by anti-melittin antibodies

Polyclonal rabbit antibodies against melittin recognize human C protein C9 and retard C9-mediated hemolysis. Human C9 contains a tetrameric and a pentameric sequence (amino acids 293-296 and 528-532, respectively) that together match a continuous segment in the melittin sequence, i.e., residues 8-16. It has been suggested that the tetrameric and the pentameric regions on C9 form a discontinuous epitope on folded C9 that mimics the structure of melittin. To further test this hypothesis, antibodies to C9-sequence-specific peptides were prepared. Peptides containing either the homologous tetrameric or the homologous pentameric sequence together with short stretches of the respective amino- and carboxyl-terminal flanking regions were synthesized, as well as a composite peptide predicted to resemble the discontinuous epitope as a linear, nine-amino acid sequence. Direct and competitive binding assays demonstrated that the tetrameric and the pentameric sequences are part of the epitope on human C9 that is recognized by anti-melittin IgG. However, only antibodies directed against the complete epitope are capable of inhibiting hemolysis. Because neither anti-tetramer nor anti-pentamer antibodies affect hemolysis whereas anti-melittin and anti-composite antibodies do, we propose that human C9 changes conformation around a hinge located between residues 296 and 528 and that the latter two antibodies inhibit unfolding required for membrane insertion and subsequent hemolysis.     

A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids

We have recently isolated a human phospholipase A2-activating protein (PLAP) that shares antigenic and biochemical similarities with melittin, a well characterized bee venom phospholipase-stimulatory peptide. To explore the potential mechanisms of action of PLAP that extend beyond its effects on eicosanoid synthesis, we examined its effects on the release of human neutrophil lysosomal enzymes and superoxide, and on RBC hemolysis. These results were compared to the effects of melittin, which has been reported to induce enzyme release and hemolysis. We also examined the effects of PLAP on neutrophil aggregation and chemotaxis. PLAP induced neutrophils to release beta-glucuronidase and metalloproteinase enzyme activities as well as produce superoxide ion in both a dose- and time-dependent manner. Eicosanoid synthesis inhibitors did not abrogate these responses. PLAP induced release of arachidonic acid metabolites, but this response could be abrogated by eicosanoid synthesis inhibitors. PLAP also induced neutrophil aggregation and chemokinesis, but not chemotaxis. Concentrations of PLAP that induced these responses did not induce cellular toxicity as determined by light and electron microscopy, lactic dehydrogenase release, trypan blue dye exclusion, and RBC hemolysis. In contrast, prolonged incubation with higher concentrations of PLAP induced cell death that was similar to that observed with melittin. These findings suggest that the mechanisms of action of PLAP extend beyond the eicosanoid synthetic pathway, and that disordered regulation of PLAP may be responsible, at least in part, for chronic immune and inflammatory states.     

Sequence requirements for the activity of membrane-active peptides.

Synthetic peptides were constructed with the sequence of the first 20 residues of melittin and terminating with a range of different amino acid amides. These were found to have haemolytic and cytolytic activity similar to that of melittin, provided that certain charge constraints were observed. The nature of the 21st residue was not critical except when the residue introduced a negative charge. The presence of at least two positive charges in the molecule was found to be essential for activity. One of these charges could be the amino-terminal amine. Peptides could be inactivated by the addition of a non-acidic presequence which was acetylated at the N-terminus. Introducing a protease cleavable sequence into an N-terminal extension of the peptides produced analogues with low haemolytic activity that could be activated by proteolytic action. A peptide with extra positive charges introduced on the hydrophilic face of the helix possessed a haemolytic activity that was greater than that of melittin.     

Lytic activity of monomeric and oligomeric melittin

The haemolytic activities of melittin and melittin tetramer as induced by high phosphate counterion concentration, were monitored. Monomeric melittin was found to be fully lytic, whilst tetrameric melittin lacked such activity. Under conditions where melittin was fully tetrameric attempts were made to covalently cross-link the native tetramer using a series of different chain length bifunctional imido esters. The cross-linked oligomers were fully lytic under conditions where melittin was demonstrated to lack such activity. This finding, together with molecular weight determinations and circular dichroism studies, indicated that the cross-linked melittin was quite different to the native tetramer. The haemolytic activity of melittin-containing solutions was related to the concentration of monomeric melittin. The effect of reduced dielectric constant (?) on the aggregation behaviour of melittin and its derivatives was found to favour monomeric melittin.     

Antibacterial peptides designed as analogs or hybrids of cecropins and melittin.

Eight new analogs of cecropin A, two new analogs of melittin and 30 hybrid peptides containing sequences from cecropins and melittin have been synthesized. The lengths of the peptides have varied from 37 residues (the length of cecropin A) to 18 residues. The peptides have been assayed for lysis of sheep red blood cells and for antibacterial activity against two Gram negative and three Gram positive bacteria. The best analogs of cecropin A maintained the anti-Escherichia coli activity of the parental peptide, and were not lytic for red blood cells. Melittin and its replacement analogs were all lytic for red blood cells, but an analog with transposed segments was not. Several of the hybrid peptides were found to be both non-hemolytic and highly active against all test bacteria. The data were used to define the structural requirements for antibacterial activity.